HMGCR and neoplasm: The use of statins to target HMG-CoA reductase can increase tumor-specific apoptosis, induce cell cycle arrest, and inhibit tumor growth (Nishida et al., 2005; Bjarnadottir et al., 2015; Sethunath et al., 2019).